Curriculum Vitae

Allergenic Products Advisory Committee

Jay M. Portnoy, MD

Chief, Section of Allergy, Asthma & Immunology
The Children’s Mercy Hospital
2401 Gillham Road
Kansas City, MO 64108
……………………….
………………..
Jportnoy@cmh.edu (e-mail)

Birthdate:
……………

Licenses:

Missouri

Kansas

Board Certifications:

American Board of Allergy/Immunology - Oct. 1985, Recertified Oct. 1995
American Board of Pediatrics - Jan. 1985
National Boards - 1981

Education:

Allergy/Immunology Fellowship 1983-85
University of Michigan School of Medicine
Ann Arbor, MI 48109

Pediatric Resident 1980-83, The Children’s Mercy Hospital
Kansas City, Missouri 64108

Medical School 1976-80. Received MD May 1980
University of Missouri-Columbia School of Medicine Columbia, Missouri 65212

Undergraduate 1974-76. Received BS, Magna Cum Laude 1976
University of Michigan, Ann Arbor, Michigan 48109

California Institute of Technology 1972-74
Pasadena, California.

Organizations:

Fellow, American Academy of Pediatrics (AAP)
Fellow, American College of Allergy, Asthma, and Immunology (ACAAI)
Fellow, American Academy of Allergy, Asthma, and Immunology (AAAAI)
Medical Advisor, Asthma and Allergy Foundation of America (AAFA)
Member, American Medical Association (AMA)
Member, Food Allergy and Anaphylaxis Network (FAAN)
Member, Society for Pediatric Research (SPR)

Offices and Board of Directors:

Board of Directors. American Lung Assn of Missouri. 2004-present.
Board of Directors, American Lung Assn of Western Missouri. 1998-2003
Board of Directors. Asthma Camp Consortium. 1996-2001
Board of Regents, American College of Allergy, Asthma, and Immunology- 1994 to 1997
Board of Directors, Joint Council of Allergy and Immunology - 1991 to 1995
President, Missouri State Allergy Society – 1993-95
Board of Directors, Missouri State Allergy Society - 1989-91
President, Kansas City Allergy Society - 1988.

Editorships and Editorial Boards

Section Editor, Annals of Allergy and Asthma. Appointed 2002 to present.
Editor, Current Allergy and Asthma Reports. Issue on Pediatric Allergy. 2004; 4(6)
Editor, Current Allergy and Asthma Reports. Issue on Pediatric Allergy. 2003; 3(6)
Editor, Current Allergy and Asthma Reports. Issue on Pediatric Allergy. 2002; 2(6)
Editor, Current Allergy and Asthma Reports. Issue on Pediatric Allergy. 2001; 1(6)
Editorial Board, Allergy Watch. 1998-2001.
Editorial Board, Annals of Allergy and Asthma. 1994 to present
Editorial Board, Current Allergy Practice. 1993 to present

Committees:

American College of Allergy, Asthma & Immunology

Chair, Allied Health Committee. 2004 – present
Co-Chair, Indoor Allergy Media Campaign. 2004
Chair, Meet the professor breakfast committee. 2000-present
Chair, Publications Committee- 1997-2001
Chair, Professional Education Committee. 1997-2001
Immunotherapy committee. 1998-present. Chair 2003-present.
Joint Taskforce of Primary Care Rotations. 1996 – present. Co-Chair 1996-1998 and 2001 – present
Board review committee. 1998-present. Chair 2004.
Program Committee. 1997 and 2000-present
Public relations network. 1999-present.
Pediatrics Committee. 1990 – present
Allied Health Professionals Committee. 2003 – present.
Technology and computers committee. 1997-present.
Training Program Directors Committee, AAAAI and ACAAI. 1987-present
Aerobiology Committee. 1998-present. Chair 2000 – 2002.
Finance committee. 1997-2001.
Chair, Inner City Asthma Committee- 1994-1997
CME Committee 1987-1991
Respiratory Diseases Committee

American Academy of Allergy, Asthma & Immunology

Member, Aerobiology Committee. Chair, 2000-2002
Residency Review Subcommittee. 2000-present
Information Technology Taskforce. 2000- present
Ad Hoc committee for computerizing allergy training programs. 2000-present
Allergy and Immunology MKSAP, 3rd Edition author group. 2000-2002.
Workshop Committee. 2000-2003.
Executive committee of the Allergen Standardization Committee- 1994-2000
Asthma camps committee- 1991-2001
Environmental and Occupational Disorders Interest Section- Workshops committee representative 2000-2003
Medical informatics committee- 1991-present
Quality of care for asthma committee- 1991-present
National Issues Committee. 1993-1996.

Other committees

Joint AAAAI/ACAAI Advocacy Working Group. ACAAI representative. 2004
Joint Taskforce on Practice Parameters. 1998-present. Co-chair 2001 – present
CPT committee, Joint Council of Allergy, Asthma & Immunology. 2000-present
Chair, National Allergy Bureau oversight committee. 2000-2002
Executive committee of the Allergy/Immunology Section. Am Acad Pediatrics. 1995-1997.
Training Program Directors Committee, AAAAI and ACAAI. 1987-present
Steering Committee. Aspen Allergy Conference. 1997-present.
Asthma & Allergy Foundation Investigator Award Review Panel. 1997-present.
American Lung Association National Grant Review Panel. 1998-present.

Local committees

Chair, Clinical Practice Guidelines Taskforce. Children’s Mercy Hospital. 2001-present.
Project director, Asthma disease management program. Children’s Mercy Hospital. 2001-present.
Appointed to Quality Council. Children’s Mercy Hospital. 2002-present.
Internet Steering Committee, Children's Mercy Hospital. 1995-present.
Chair, Asthma Disease Management Taskforce. Family Health Partners. 2000

Academic Appointments:

Professor of Pediatrics, University of Missouri-Kansas City School of Medicine. 1997-present.
Associate Professor of Biologic Sciences, University of Missouri-Kansas City School of Biologic Sciences
Director, University of Missouri-Kansas City Allergy Fellowship Training Program. 1997-present
Co-Director, Children’s Mercy /Kansas U. Allergy/Immunology Fellowship Training Program 1985-97
Chief, Section of Allergy/Asthma/Immunology, The Children’s Mercy Hospital. 1985-present.

Honors and Awards

Bela Schick Lectureship. ACAAI. 2004
Distinguished Fellow Award. ACAAI. 2001
Distinguished Service Award. ACAAI. 1999
Pharmacia Allergy Research Foundation Fellowship. 1994
Kraemer Research Award. Children's Mercy Hospital. 1993

Publications:

  1. Lieberman P, Bernstein IL, Nicklas R, … Portnoy J, et al. Practice Parameter for the Diagnosis and Management of Anaphylaxis. J Allergy Clin Immunol. 2005: 115(3,suppl).

  2. Bonilla A, Bernstein IL, Nicklas R, … Portnoy J, et al. Practice Parameter for the Diagnosis and Management of Primary Immunodeficiency. Ann Allergy Asthma Immunol. 2005; 94(5 suppl 1).

  3. Portnoy JM, Kennedy K, Barnes C. Sampling for indoor fungi: what the clinician needs to know. Curr Opin Otolaryngol Head Neck Surg 2005;13(3):165-170.

  4. Portnoy J, Kwak K, VanOsdol T, Dowling P, Barnes C. Health Effects of Indoor Fungi. Ann Allergy Asthma Immunol. 2005; 94(3): 313-9.

  5. Portnoy J, Barnes CS. The National Allergy Bureau: pollen and spore reporting today. J Allergy Clin Immunol 2004;114(5):1235-8.

  6. Portnoy J, VanOsdol T, Williams PB. Evidence-Based Strategies for Treatment of Allergic Rhinitis. Current Allergy and Asthma Reports. 2004 ; 4 : 439-46.

  7. Adams C, Dryer M, Dinakar, C, Portnoy, J. Pediatric Asthma: A look at adherence from the patient and family perspective. Current Allergy and Asthma Reports. 2004 ; 4 : 425-32.

  8. Leung DYM, Nicklas R, Li J, Bernstein IL, Blessing-Moore J, Boguniewicz M, Chapman J, Khan D, Lang D, Lee R, Portnoy JM, Schuller D, Spector S, Tilles S. Disease Management of Atopic Dermatitis: An Updated Practice Parameter. Ann Allergy Asthma Immunol. 2004; 93 (3 suppl 2): S1-S21.

  9. Portnoy J, Dinakar C. Review of cetirizine hydrochloride for the treatment of allergic disorders. Expert Opin Pharmacother. 2004; 5(1): 125-35.

  10. Dinakar C, Portnoy JM. Allergen immunotherapy in the prevention of asthma. Curr Opin Allergy Clin Immunol. 2004; 4(2): 131-136. 11.

  11. Children’s hospital. Current Allergy and Asthma Reports. 2003; 3(6), 491-500.

  12. Jones EM, Portnoy J. Modification of provider behavior to achieve improved asthma outcomes. Current Allergy and Asthma Reports. 2003; 3(6), 484-90.

  13. Portnoy J, Barnes C. Clinical relevance of spore and pollen counts. Immunol Allergy Clin N. America. 2003; 23(3):389-410.

  14. Williams PB, Ahlstedt S, Barnes JH, Soderstrom L, Portnoy J. Are our impressions of allergy test performances correct? Ann Allergy Asthma Immunol 2003;91(1):26-33.

  15. Spector SL, Nicklas RA, Chapman JA, Bernstein IL, Berger WE, Blessing-Moore J, Dykewicz M. S., Fineman S. M, Lee R. E., Li J. T, Portnoy J. M., Schuller D. E., Lang D.Tilles, S. A.. Symptom severity assessment of allergic rhinitis: part 1. Ann Allergy Asthma Immunol 2003;91(2):105-14.

  16. Simons FE, Silas P, Portnoy JM, Catuogno J, Chapman D, Olufade AO, et al. Safety of cetirizine in infants 6 to 11 months of age: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol 2003;111(6):1244-8

  17. Portnoy J, Jones E. Pediatric asthma emergencies. J Asthma 2003;40 Suppl:37-45

  18. Li J, Lockey R, Bernstein I, Portnoy J, Nicklas R. Allergen immunotherapy: a practice parameter. Ann Allergy 2003;90(1)

  19. Portnoy JM, Jones EM. Diagnosing asthma in young children. Current Allergy and Asthma Reports. 2002; 2(6), 447-52.

  20. Barnes CS, Pacheco F, Buckley S, Portnoy JM. IgE Reactive Proteins from Stachybotrys chartarum. Annals of Allergy Asthma and Immunology. 2002; 89(1): 29-33.

  21. Barnes CS, Pacheco F, Landuyt J, Hu F, Portnoy JM. The effect of temperature, relative humidity and rainfall on airborne ragweed pollen concentrations. Aerobiologia. 2001; 17: 61-8.

  22. Esch R, Portnoy JM. Allergen Immunotherapy. Current Allergy and Asthma Reports. 2001; 1(6), 491-7.

  23. Portnoy JM. Immunotherapy for allergic diseases. Clin Rev Allergy Immunol:2001:21(2-3):241-259.

  24. Graft DF, Bernstein DI, Goldsobel A, Meltzer EO, Portnoy JM. Long J. Safety of fexofenadine in children treated for seasonal allergic rhinitis. Ann Allergy Asthma Immunol: 2001:87(1):22-26.

  25. Portnoy JM. Immunotherapy for asthma: Unfavorable studies. Ann Allergy. 2001; 87(Suppl), 28-32.

  26. Barnes CS, Tuck J, Simon S, Pacheco F, Hu F, Portnoy JM. Allergenic materials in the house dust of allergy clinic patients. Ann Allergy. 2001; 86; 517-23.

  27. Portnoy JM. Immunotherapy for inhalant allergies. Postgraduate Medicine. 2001: 109(5); 89-106.

  28. Portnoy JM. Flappan S, Barnes CS. A procedure for evaluation of the indoor environment. Aerobiologia. 2001; 17; 43-48.

  29. Williams PB, Siegel C, Portnoy JM. Efficacy of a single diagnostic test for sensitization to common inhalant allergens. Ann Allergy. 2001 86; 196-202.

  30. Barnes CS, Pacheco F, Landuyt J, Hu F, Portnoy JM. Hourly Variation Of Airborne Ragweed Pollen In Kansas City. Ann Allergy. 2001; 86; 166-71.

  31. Bush R, Portnoy JM. The role and abatement of fungal allergens in allergic disease. J Allergy Clin Immunol. 2001; 107: S430-40.

  32. Williams PB, Siegel C, Portnoy JM. UniCAP Phadiotop- An accurate test for sensitization to common inhalant allergens. Allergy. 2000; 55:269-70.

  33. Barnes C, Schreiber K, Pacheco F, Landuyt J, Hu F, and Portnoy JM. Comparison of outdoor allergenic particles and allergen levels. Annals of Allergy, Asthma and Immunology. 2000: 84; 47-54.3

  34. Portnoy JM, Landuyt J, Pacheco F, Simon S, and Barnes C. A Comparison of the Burkard and Allergenco MK-3 Volumetric Collectors. Annals of Allergy, Asthma and Immunology. 2000; 84: 19-24.

  35. Flappan S, Portnoy JM, Jones P, Barnes C. Infant Pulmonary Hemorrhage in a Suburban Home with Water Damage and Stachybotrys. Environ Health Perspect 1999; 107 (11): 927.

  36. Miller C, Flappan S, Portnoy JM. Improved Asthma Control after Remediation of Environmental Stachybotrys Contamination. Resp Reviews. 1999; 4(3), 30-2.

  37. Bernstein IL, Gruchalla R, Lee R, Nicklas R, Dykewicz M, et al. Disease Management of Drug Hypersensitivity: A Practice Parameter. Annals of Allergy, Asthma, and Immunology. 1999; 83 (6), 665-700.

  38. Portnoy JM, Moffitt J, Golden D, Bernstein IL, et al. Stinging Insect Hypersensitivity: A Practice Parameter. J Allergy Clin Immunol. 1999: 103(5); 963-80.

  39. Portnoy JM, Brothers D, Pacheco F, Landuyt J, Barnes C. Monoclonal antibody-based assay for Alt a1, a major Alternaria allergen. Ann Allergy Asthma Immunol 1998;81(1):59-64.

  40. Rosenthal D, Hu F, Pacheco F, Landuyt J, Barnes C, Portnoy JM. Northern blot identification of mRNA containing sequence for protein allergen, Alt a1, in eight strains of Alternaria alternata. Ann Allergy Asthma Immunol 1998;80(6):471-5.

  41. Li J, Pearlman D, Nicklas R, Lowenthal M, Rosenthal R, Bernstein IL, Berger W, Kykewicz M, Fineman S, Lee R, Portnoy JM, Spector S. Algorithm for the diagnosis and management of asthma: a practice parameter update. Ann Allergy. 1998; 81 (5pt1),415-20.

  42. Portnoy JM, Finegold I. Ragweed immunotherapy in adult asthma [letter; comment]. N Engl J Med 1996;335(3):203-4; discussion 205-6.

  43. Barnes CS, Pacheco F, Landuyt J, Rosenthal D, Hu F, Portnoy JM. Production of a recombinant protein from Alternaria containing the reported N-terminal of the Alt a1 allergen. Adv Exp Med Biol 1996;409:197-203.

  44. Cage BR, Schreiber K, Barnes C, Portnoy JM. Evaluation of four bioaerosol samplers in the outdoor environment. Ann Allergy Asthma Immunol 1996;77(5):401-6.

  45. Sharkey P, Portnoy JM. Rush immunotherapy: experience with a one-day schedule [see comments]. Ann Allergy Asthma Immunol 1996;76(2):175-80.

  46. Friesen CA, Wiens, LA, Burry VF, Portnoy JM, Roberts CC. C-Reactive protein in acute pulmonary exacerbations of patients with cystic fibrosis. Pediatric Pulmonology. 1995: 20, 215-9.

  47. Portnoy JM, King K, Kanarek H. Premedication reduces the incidence of systemic reactions during rush immunotherapy. Ann Allergy. 1994: 73(5) , 409-18.

  48. Portnoy JM, Pacheco F, Upadrashta B, Barnes C. A double monoclonal antibody assay for the Alternaria allergen GP70. Annals of Allergy 1993;71(4):401-7.

  49. Chipps B, Sullivan W, Portnoy JM. Alpha-2A-interferon for treatment of bronchiolitis caused by respiratory syncytial virus. Pediatr Infec Dis J. 1993; 12(8), 653-8.

  50. Barnes C, Upadrashta B, Pacheco F, Portnoy JM. Enhanced sensitivity of immunoblotting with peroxidase conjugated antibodies using an immobilized substrate method. J Chromatography. 1993; 613(2),281-8.

  51. Portnoy JM, Pacheco F, Barnes C, Upadrashta B, Crenshaw R, Esch R. Selection of representative Alternaria strain groups based on morphology, enzyme profile, and allergen content. J Allergy Clin Immunol. 1993;91(3),773-82.

  52. Portnoy JM, Pacheco F, Ballam Y, Barnes C. The effect of time and extraction buffers on residual protein and allergen content of extracts derived from four strains of Alternaria. J Allergy Clin Immunol. 1993; 91(4),930-8.

  53. Wiens L, Sabath R, Ewing L, Gowdmarajan R, Portnoy JM, Scagliotti D. Chest pain in children and adolescents is frequently caused by exercise-induced asthma. Pediatrics. 1992;90(3):350-3.

  54. Portnoy JM, Nadel G, Amado M, Willsie–Ediger S. A Review of Continuous Nebulization of Beta Agonists in Status Asthmaticus. Ann Allergy. 1992;69(1):71-9.

  55. Portnoy JM, King K, Kanarek H, Horner S. Incidence of systemic reactions during rush immunotherapy. Ann Allergy. 1992;68(6):493-8.

  56. Guss S, Portnoy JM. Methotrexate treatment of severe asthma in children. Pediatrics. 1992;89(4):635-9.

  57. Portnoy JM. Diagnosis of Allergic Diseases. Children’s Hospital Quarterly. 1991; 2(2),181-4.

  58. Portnoy JM. Management of Allergic Rhinitis. Children’s Hospital Quarterly. 1991; 2(2),185-9.

  59. Horner S, Guss S, Portnoy JM. Immunodeficiency Associated with a Complete Lack of CD8 Cells. Immunol & Allergy Prac. 1991;13(2),17-21.

  60. Portnoy JM, Pacheco F, Ballam Y, Barnes C. Separation of Alternaria into Protein and Carbohydrate Fractions Using Phenylsepharose. J Allergy Clin Immunol. 1991;87,789-93.

  61. Estrada V, Portnoy JM. Diabetes Insipidus Exacerbated by Allergic Rhinitis. Immunol & Allergy Prac. 1990;12,13-6.

  62. Portnoy JM, Olson I, Pacheco F, Barnes C. Affinity Purification of a Major Alternaria Allergen Using a Monoclonal Antibody. Ann Allergy. 1990; 65,109-14.

  63. Estrada V, King K, Portnoy JM. The use of home nebulizers for the prevention of asthma-related morbidity. Ped Asthma, Allergy, Immunol. 1989; 3(4); 227-31.

  64. Gill F, Portnoy JM. An unusual combination of immunologic abnormalities in a patient with Chronic Mucocutaneous Candidiasis. Ann Allergy. 1989;63, 98.

  65. Portnoy JM, Hicks R, Pacheco F, Olson L. A pilot study of recombinant interferon-alpha for treatment of infants with Respiratory Syncytial Virus-induced bronchiolitis. Antimicrobial Agents and Chemotherapy. 1988;32,589

  66. Portnoy JM, Aggarwal J. Continuous terbutaline nebulization for the treatment of severe exacerbations of asthma in children. Ann Allergy. 1988;60,368.

  67. Portnoy JM, Chapman J, Burge H. Muilenberg M. Solomon W. Epicoccum allergy: skin reaction patterns and spore/mycelium disparities recognized by IgG and IgE ELISA inhibition. Annals of Allergy. 1987:59,39.

  68. Fitzmaurice L, Portnoy JM. A Patient With Functional Humoral Immunodeficiency and Normal Quantitative Immunoglobulins. Immunology and Allergy Practice. Immunology & Allergy Practice. 1987; 9, 220.

  69. Aggarwal J, Portnoy JM. Intractable sneezing with a specific psychogenic origin. Annals of Allergy, 1986:56,345.

  70. Portnoy JM, Olson L. Normal cerebrospinal fluid values in children: Another look. Pediatrics. 1985:75,484-87

  71. Sarnat HB, Portnoy JM, Chi DY. Effects of denervation and tenotomy on the gastrocnemius muscle in the frog: a histologic and histochemical study. Anat Rec. 1977;187(3):335-46.

Editorials:

  1. Portnoy JM. Rhinitis therapy in preventing hospitalization for asthma. Curr Allergy Asthma Rep 2004 Nov;4(6):424.

  2. Portnoy JM. Exhaled Nitric Oxide versus conventional tests for asthma. Curr Allergy Asthma Rep 2004 Nov;4(6):423.

  3. Portnoy JM. Strategies for evaluating allergic rhinitis. Curr Allergy Asthma Rep 2004 Nov;4(6):423.

  4. Portnoy JM. In my opinion – Interview with the Expert. Pediatric Asthma Allergy & Immunol. 2004; 17(2), 156-60.

  5. Portnoy JM. What do Pollen Counts Mean? Ann Allergy Asthma Immunol. 2004; 93(2), 109-10.

  6. Portnoy JM, Improving childhood asthma outcomes in the United States. Curr Allergy Asthma Rep 2003 Nov;3(6):466

  7. Portnoy JM, Pediatric asthma management programs. Curr Allergy Asthma Rep 2003 Nov;3(6):465

  8. Portnoy JM, Daily controller medicine in children with mild persistent asthma. Curr Allergy Asthma Rep 2003 Nov;3(6):465

  9. Portnoy JM, Simon SD. Is 3-mm less drowsiness important? Ann Allergy Asthma Immunol. 2003; 91(4):324-25.

  10. Portnoy JM. Outcomes to measure the effectiveness of asthma treatment. Ann Allergy Asthma Immunol. 2003; 91(3):220-21.

  11. Portnoy JM. Evaluation of indoor mold exposure is what allergists do best. Ann Allergy Asthma Immunol 2003;90(2):175.

  12. Portnoy JM, What do allergy skin tests really mean? Annals of Allergy Asthma and Immunology. 2002; 89(4): 335-6.

  13. Portnoy JM, Relationship of adherence to pediatric asthma morbidity among inner-city children. Curr Allergy Asthma Rep 2002

    Nov;2(6):445-6

  14. Portnoy JM, A qualitative study of action plans for asthma. Curr Allergy Asthma Rep 2002 Nov;2(6):445

Book Chapters:

  1. Fischer T, Gruchalla R. Allergy and Immunology Medical Knowledge Self-Assessment Program (MKSAP). Chapters on Insect Sensitivity, Asthma, and Immunotherapy. 2003.

  2. Mathews K. Portnoy JM, Allergic Rhinitis. in: Current Therapy in Allergy. Immunology and Rheumatology. Lichtenstein & Fauci eds. B C Decker Inc-Publisher. 1984.

 
Updated: January 5, 2006